← Back to Search

Radiation Therapy

Stereotactic Radiosurgical Boost for Prostate Cancer (CCRO025 Trial)

Phase 1
Waitlist Available
Led By Richard Valicenti, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

CCRO025 Trial Summary

This trial is testing whether it is safe to give radiation therapy to the prostate after whole-pelvic radiation therapy in men with unfavorable intermediate or high risk prostate cancer.

Eligible Conditions
  • Prostate Cancer

CCRO025 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tumor Assessment
Secondary outcome measures
Zubrod Performance Scale

CCRO025 Trial Design

1Treatment groups
Experimental Treatment
Group I: SingleExperimental Treatment3 Interventions
Neoadjuvant Androgen Blockade (Casodex) Followed by: Intensity Modulated Radiotherapy (IMRT)2 with Concurrent Androgen Blockade (Casodex and Leuprolide) to Whole Pelvis, Prostate, and Seminal VesiclesFollowed by: Stereotactic Radiosurgical Boost3 to the Prostate with Implanted Electromagnetic Transponder Beacon Intrafraction Guidance Followed by: Adjuvant Androgen Blockade (Casodex)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Radiosurgical Boost
2013
Completed Phase 1
~20
Goserelin
FDA approved
Bicalutamide
FDA approved

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
911 Previous Clinical Trials
4,709,502 Total Patients Enrolled
14 Trials studying Prostate Cancer
1,829 Patients Enrolled for Prostate Cancer
Richard Valicenti, MDPrincipal InvestigatorUniversity of California, Davis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate
2013. "Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02064036.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top